E-LIB Suche - Ergebnisse für: Blauvelt, Andrew

1

Deucravacitinib Long-Term Efficacy in Week 16 Placebo Cross..:

Lebwohl, Mark ; Warren, Richard B. ; Imafuku, Shinichi...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s365 , 2024

Link: https://doi.org/10.25251..

2

526 - Efficacy of upadacitinib vs dupilumab for moderate-to..:

Blauvelt, Andrew ; de Bruin-Weller, Marjolein ; Kwatra, Shawn G...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii28-ii29 , 2024

Link: https://doi.org/10.1093/..

3

505 - Once-daily roflumilast cream 0.15% for atopic dermati..:

Eichenfield, Lawrence F ; Boguniewicz, Mark ; Simpson, Eric L...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii10-ii11 , 2024

Link: https://doi.org/10.1093/..

4

Factors Associated with Persistent Efficacy of Abrocitinib ..:

Thyssen, Jacob ; Silverberg, Jonathan ; Blauvelt, Andrew...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s378 , 2024

Link: https://doi.org/10.25251..

5

Targeting IL‐13 with tralokinumab normalizes type 2 inflamm..:

Guttman‐Yassky, Emma ; Kabashima, Kenji ; Staumont‐Salle, Delphine...
Allergy. 79 (2024) 6 - p. 1560-1572 , 2024

Link: https://doi.org/10.1111/..

6

Safety and efficacy of eblasakimab, an interleukin 13 recep..:

Veverka, Karen A. ; Thng, Steven T.G. ; Silverberg, Jonathan I....
Journal of the American Academy of Dermatology. 90 (2024) 3 - p. 504-511 , 2024

Link: https://doi.org/10.1016/..

7

Bimekizumab 3-year Maintenance of Response in Week 16 Respo..:

Thaçi, Diamant ; Armstrong, April ; Gordon, Kenneth B...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s306 , 2024

Link: https://doi.org/10.25251..

8

Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in t..:

Blauvelt, Andrew ; Korman, Neil J. ; Merola, Joseph F....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s364 , 2024

Link: https://doi.org/10.25251..

9

Efficacy, Safety, and Long-Term Disease Control of Ruxoliti..:

Eichenfield, Lawrence F. ; Simpson, Eric L. ; Papp, Kim...
American Journal of Clinical Dermatology. , 2024

Link: https://doi.org/10.1007/..

10

551 - Continuous tralokinumab treatment over 4 years in adu..:

Blauvelt, Andrew ; Langley, Richard G ; Peris, Ketty...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii48-ii49 , 2024

Link: https://doi.org/10.1093/..

11

Comparing Achievement of National Psoriasis Foundation Trea..:

Armstrong, April ; González-Cantero, Alvaro ; Khattri, Saakshi...
Dermatology and Therapy. 14 (2024) 4 - p. 933-952 , 2024

Link: https://doi.org/10.1007/..

12

502 - Efficacy and safety of upadacitinib through 140 weeks..:

Silverberg, Jonathan I ; Guttman-Yassky, Emma ; Simpson, Eric L...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii8-ii8 , 2024

Link: https://doi.org/10.1093/..

13

Deucravacitinib in plaque psoriasis: 2-year safety and effi..:

Lebwohl, Mark ; Warren, Richard B ; Sofen, Howard...
British Journal of Dermatology. 190 (2024) 5 - p. 668-679 , 2024

Link: https://doi.org/10.1093/..

14

552 - Improvement of the head and neck regions with continu..:

Chovatiya, Raj ; Wollenberg, Andreas ; Ribero, Simone...
British Journal of Dermatology. 190 (2024) Supplement_2 - p. ii49-ii50 , 2024

Link: https://doi.org/10.1093/..

15

Bimekizumab Continuous Maintenance of Eesponse at Every Vis..:

Blauvelt, Andrew ; Conrad, Curdin ; Costanzo, Antonio...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s303 , 2024

Link: https://doi.org/10.25251..